Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:24 PM
Ignite Modification Date:
2025-12-24 @ 9:24 PM
NCT ID:
NCT06788132
Eligibility Criteria:
Inclusion Criteria:
* Patients who agree to participate in the study.
* Patients who sign the informed consent form.
* Patients who can read and write.
* Patients without alterations in the cognitive system.
* Patients who had their delivery at the Maternal and Child Hospital.
* Patients with admission criteria for conservative management in the pathology ward of the Hospital Escuela.
* Patients with a single non-abnormal fetus.
* Premature rupture of membranes with pregnancy of \>24.0 and \<34.0 weeks of gestation.
Exclusion Criteria:
* Patients who do not wish to participate in the study
* Fetus with pulmonary anomalies, central nervous system and cardiopathies.
* Patient with chorioamnionitis.
* Premature rupture of membranes experienced within 14 days after amniocentesis or cervical cerclage placement.
* Multiple gestation.
* Delivery within 24 hours after admission.
* Intrauterine fetal death at presentation.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
45 Years
Study:
NCT06788132
Study Brief:
Protocol Section:
NCT06788132